CrowdStrike’s Split Aftermath: A Record Quarter Overshadowed by Technical Noise

CrowdStrike shares fell 5.6% post-split, erasing $11B in market cap; strong ARR growth contrasts with mixed analyst targets ranging from $172 to $235.

The arithmetic of a stock split can be brutally simple, yet its market psychology is anything but. CrowdStrike Holdings lost roughly $11 billion in market capitalization on Friday, a drop of 5.63 percent that dragged its shares to €163.84. The S&P 500 and Nasdaq, meanwhile, spent the day grinding higher — the cybersecurity specialist was very much on its own.

No negative corporate news triggered the slide. Instead, analysts point to a familiar combination: profit-taking after a blistering run and residual noise from the 4-for-1 stock split that took effect on July 2. Lower per-share prices tend to attract retail buyers, but they also give short-term traders a clean exit. In the 30 days before Friday, CrowdStrike had rallied 16.80 percent, but the weekly performance now stands at minus 4.47 percent. The selloff also erased the 4 percent bounce from Thursday, leaving the stock roughly 11 percent below the all-time high set on July 6.

The 14-day relative strength index of 56.7 suggests the shares are neither overbought nor oversold, while the annualized 30-day volatility of 45.28 percent signals that sharp intraday swings are likely to continue. Whether Friday marked a genuine trend shift or just a technical breather after the split remains an open question.

Conflicting Signals from Wall Street

The analyst community is split on what comes next — a debate that has grown louder since the split changed the nominal price levels. UBS reaffirmed its buy rating and lifted its target to $235, a bet that demand for AI-powered security will fuel another growth cycle. Benchmark followed suit, raising its price objective to $230. Both see further upside even after the split adjustment.

Other houses are more circumspect. Morgan Stanley kept its "Overweight" rating but trimmed its target to $172, just a step above Friday’s close, reflecting concern that much of the expected growth is already baked into the valuation. Stifel cut its target from $790 to $220 in a purely mechanical move to reflect the new share count. The wide range underscores a central tension: the stock has already gained 69 percent year to date, and the forward price-to-earnings multiple of 161 leaves little room for error. A separate adjusted P/E figure of 188 — based on reported earnings — further highlights the premium.

Operating Momentum Defies the Noise

Beneath the price volatility, the business continues to fire on all cylinders. In the first quarter of fiscal 2027, which ended April 30, total annual recurring revenue (ARR) reached $5.51 billion, up 24 percent year over year. Net new ARR hit a record $256 million, a 32 percent jump from the prior year. The company’s AI detection offering, AIDR, posted a 250 percent sequential increase in its ARR base, driven by the flagship Falcon Flex program, which doubled its own ARR to $1.9 billion.

Revenue climbed 26 percent to $1.39 billion, and adjusted earnings per share came in at $1.10. Management responded by raising the full-year outlook: the midpoint of the ARR guidance range increased by $50 million to $6.54 billion, while the revenue forecast was lifted to roughly $5.9 billion. CEO George Kurtz has framed the narrative succinctly: the more companies adopt artificial intelligence, the more they need CrowdStrike’s Falcon platform as the security backbone.

Valuation Remains the Sticking Point

Even the most optimistic operational metrics struggle to justify a price-to-sales ratio of 38.7 — the highest since the 2019 initial public offering and well above most cybersecurity peers. Some market observers argue that near-term upside potential is limited, and that anyone hunting for quick gains over the coming months may be disappointed.

The next major checkpoint comes on August 26, when CrowdStrike reports its second-quarter results. That will be followed by its "Day Zero" research symposium on current threat landscapes from August 30 to September 1. Both events will test whether the company's breakneck growth can continue to support a valuation that leaves no room for disappointment. Until then, the split-induced volatility and the enduring debate over price versus promise are likely to keep the stock in a tight, nervy range.